Project Grant R21AR082631
Award Date
9/18/23
Completion Date
8/31/25
Dollars Obligated
$384K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
This $198,782 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will enable Duke University to develop genetically modified 3D human reconstructed epidermis (RHE) models. The goal is to investigate interactions between the skin microbiome and skin cell populations, including keratinocytes and fibroblasts, using CRISPR/Cas9 knockouts of key skin...
This federal Project Grant award, valued at $242,310.00, was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research at Rockefeller University to investigate the long-term impacts of allergic "type 2" skin inflammation on epithelial stem cells, which play a key role in tissue repair and adaptation. Specifically, the research aims to...
This federal Project Grant award of $249,000.00, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the mechanisms by which commensal microbes influence the development and function of cutaneous myeloid immune cells, particularly inflammatory monocytes, in early life. The principal investigator, Dr. Dhariwala, and his team at The Ohio State...
This Project Grant award of $384,363 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research at Temple University into the role of the protein Pellino1 (PELI1) in regulating antiviral immunity in the skin. The research aims to define how PELI1 functions to limit viral replication and dissemination in keratinocytes and the epidermis, using mouse models of herpes simplex virus (HSV)...
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $163,514 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Brigham & Women's Hospital Inc. in Boston, MA. The grant, awarded on July 1, 2024, supports research to biochemically define a new G protein-coupled receptor (GPCR) signaling pathway with relevance to chemokine signaling and T cell function. The principal investigator, with mentorship...
This federal Project Grant award, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to study whether remote characterization of frequent gene/module expression can identify distinctive dynamics of inter-individual variations in the blood transcriptional trajectories following treatment with TNF inhibitors and IL-17 inhibitors in early psoriatic arthritis. The...
This federal Project Grant award, valued at $551,685.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research at Duke University to investigate the roles of desmosomes, which are cell adhesion structures, in regulating the localization and translation of mRNAs. The project aims to determine the molecular mechanisms underlying the...
The National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded New York University School of Medicine $409,311.92 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) from April 5, 2021 to January 25, 2022. The project grant funding supports research into the role of T follicular helper (TFH) cells in the pathogenesis of dermatomyositis, a severe inflammatory myopathy. Specifically, the award will fund studies to...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $550,909 to the University of Pittsburgh for a 5-year research project from Jul 2024 to Jun 2029. The research aims to understand the intrinsic and extrinsic factors regulating competition for active transforming growth factor beta (TGFβ) that promote skin-resident memory CD8 T cell...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $401,433 from September 2023 to August 2025 to support research at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The research aims to investigate the role of protein O-GlcNAcylation in regulating keratinocyte function and its impact on skin...